Small molecule · Antagonist of androgen receptor (AR) · developed by Sun Pharm
Clascoterone is a topical androgen receptor inhibitor applied to the skin. It is studied in androgenetic alopecia, where it is applied twice daily to balding areas of the scalp.
Summary written with AI from the sources listed at the end of this page.
From the indications section of the FDA label (version of Jan 2, 2025). Read the full label for the exact wording, limitations and safety information.
| Trial | Phase | Condition | Status | Sponsor |
|---|---|---|---|---|
| NCT05910450 | Phase 3 | Alopecia, Androgenetic | Completed | ICLR |
Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.
Alopecia, Androgenetic
Updated Nov 15, 2026.